University of Liege
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1817-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.ulg.ac.be
Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)
Phase 2
Completed
- Conditions
- Hematologic Malignancies
- First Posted Date
- 2008-06-09
- Last Posted Date
- 2011-09-02
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 54
- Registration Number
- NCT00693927
- Locations
- 🇧🇪
CHU Sart Tilman, Liege, Belgium
Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function
Phase 2
Recruiting
- Conditions
- Graft-versus-host DiseasePoor Graft FunctionLow Donor T-cell Chimerism
- First Posted Date
- 2008-01-29
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 100
- Registration Number
- NCT00603330
- Locations
- 🇧🇪
UZA, Edeghem, Antwerpen, Belgium
🇧🇪Hôpital des enfants Reine Fabiola, Brussels, Brabant, Belgium
🇧🇪AZ VUB Jette, Brussels, Brabant, Belgium
Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings
Phase 2
Completed
- Conditions
- Hematological Malignancies
- First Posted Date
- 2008-01-29
- Last Posted Date
- 2022-01-26
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 107
- Registration Number
- NCT00603954
- Locations
- 🇧🇪
AZ Gasthuisberg Leuven, Leuven, Flamish Brabant, Belgium
🇧🇪UZ Gent, Gent, Flanders Oost, Belgium
🇧🇪University Hospital Mont-Godinne, Godinne, Namur, Belgium
Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)
Phase 2
Completed
- Conditions
- Hematological Malignancies
- Interventions
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2010-01-11
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 125
- Registration Number
- NCT00557817
- Locations
- 🇧🇪
Vrije Universiteit Brussel, Brussels, Belgium
🇧🇪Katholieke Universiteit Leuven, Leuven, Belgium
🇧🇪CHR la citadelle, Liege, Belgium
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
Phase 2
Completed
- Conditions
- Hematological Malignancies
- First Posted Date
- 2007-07-20
- Last Posted Date
- 2011-09-02
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 30
- Registration Number
- NCT00504803
- Locations
- 🇧🇪
CHU Sart Tilman, Liege, Belgium
Glucontrol Study: Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients
Not Applicable
Completed
- Conditions
- Critical Illness
- First Posted Date
- 2005-04-06
- Last Posted Date
- 2008-06-27
- Lead Sponsor
- University of Liege
- Target Recruit Count
- 3500
- Registration Number
- NCT00107601
- Locations
- 🇧🇪
C.H.U. Erasme, Bruxelles, Belgium
🇧🇪University Hospital Gasthuisberg, Leuven, Belgium
🇧🇪Centre Hospitalier Universitaire de Liège, Liege, Belgium